Cannabis scientist Dr. Matthew Hill walks Andrew Huberman through THC, CBD, the munchies, addiction, and why cannabis probably doesn't cause schizophrenia.

Dr. Matthew Hill: Professor of Cell Biology and Anatomy at the University of Calgary whose lab studies cannabis and the endocannabinoid system's effects on stress, feeding, and behavior. He publicly criticized Huberman's earlier solo cannabis episode on X, which led to this collaborative correction-and-discussion episode.
The episode is a detailed, debate-turned-collaboration about the biology of cannabis. Hill explains how THC acts on CB1 receptors and how the endocannabinoid system (anandamide and 2-AG) maintains homeostasis, then covers the munchies, memory effects, routes of administration (smoking vs. edibles vs. concentrates), tolerance, and cannabis use disorder. A long central section argues that the cannabis-schizophrenia link is likely correlation (shared biological vulnerability or self-medication) rather than causation. They also debunk the indica-vs-sativa distinction as expectancy bias, question the entire CBD wellness market as placebo at common doses, and close on genuine harms and the few evidence-backed medical uses (chronic pain, anxiety, PTSD nightmares, pediatric epilepsy).
Andrew Huberman
“I have a new book coming out it's my very first book it's entitled protocols an operating manual for the human body”— Andrew Huberman
Nicorette
“I was chewing a little bit of Nicorette gum to kind of do experiment I liked it a lot and then I decided to stop completely”— Andrew Huberman
Stanley Brothers
“he mentioned a strain of cannabis that is available in Colorado which is pure CBD I think it's called Charlotte's Web”— Andrew Huberman
Bausch Health
“synthetic forms of THC like naalone which is something you can get in Canada or Marinol or dronabinol”— Matthew Hill
AbbVie
“synthetic forms of THC like naalone which is something you can get in Canada or Marinol or dronabinol”— Matthew Hill